
UMAXLIFE is a digital psychotherapeutics and DTx technology company that specializes in evidence-based behavioral pattern recognition. They empower mental health professionals with an AI platform that enhances client outcomes and clinic efficiency by providing data-driven insights into patient behavior. Their innovative solutions include assessment, predictive assistance, progress monitoring, and risk scoring, aimed at improving the effectiveness of psychological therapies. UMAXLIFE collaborates with leading research institutions to transform technology, psychology, and healthcare integration, positioning itself as a pioneer in personalized mental healthcare.

UMAXLIFE is a digital psychotherapeutics and DTx technology company that specializes in evidence-based behavioral pattern recognition. They empower mental health professionals with an AI platform that enhances client outcomes and clinic efficiency by providing data-driven insights into patient behavior. Their innovative solutions include assessment, predictive assistance, progress monitoring, and risk scoring, aimed at improving the effectiveness of psychological therapies. UMAXLIFE collaborates with leading research institutions to transform technology, psychology, and healthcare integration, positioning itself as a pioneer in personalized mental healthcare.
Sector: Digital psychotherapeutics / DTx (mental health SaaS & mobile apps)
Headquarters: London, England, United Kingdom
Team size (reported): 11–50 (Crunchbase)
Total funding (reported): 360,000 USD
Mental health treatment effectiveness, clinician decision support, and patient progress monitoring.
Mental health / Digital therapeutics / SaaS
360000.00
Reported total funding amount and last funding date from company snapshot; Crunchbase lists seed-stage rounds with some details obfuscated.